The current crisis of confidence in antidepressants

Journal of Clinical Psychiatry

Volumn 72, Issue 1, 2011, Pages 27-33

  Nierenberg, Andrew A ^a   Leon, Andrew C ^a   Price, Lawrence H ^a   Shelton, Richard C ^a   Trivedi, Madhukar H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

DATA ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; MASS MEDIUM; NOTE; PRESCRIPTION; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TREATMENT OUTCOME;

EID: 79551570683     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10035co1c     Document Type: Note

References (21)

1. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47-53. doi:10.101/jama.209.1943
2. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45. doi:10.1371/journal.pmed.05045
3. Khan A, Leventhal RM, Khan SR, et al. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J Clin Psychopharmacol. 2002;22(1):40-45. doi:10.1097/04714-202020-07 (Pubitemid 34101291)
4. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56
5. Menand L. Head case: can psychiatry be a science? The New Yorker. March 1, 2010. http://www.newyorker.com/arts/critics/atlarge/2010/03/01/100301crat- atlarge-menand. Accessed August 12, 2010.
6. Cuijpers P, van Straten A, Andersson G, et al. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol. 2008;76(6):909-922. doi:10.1037/a013075
7. Laidlaw K, Davidson K, Toner H, et al. A randomised controlled trial of cognitive behaviour therapy vs treatment as usual in the treatment of mild to moderate late life depression. Int J Geriatr Psychiatry. 2008;23(8):843-850. doi:10.102/gps.193
8. Hollon SD, Jarrett RB, Nierenberg AA, et al. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry. 2005;66(4):455-468. doi:10.408/JCP. v6n0408
9. Gaynes BN, Warden D, Trivedi MH, et al. What did STAR*D teach us? results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv. 2009;60(11):1439-1445. doi:10.176/api.ps.60.1.1439
10. Leon AC. The revised black box warning for antidepressants sets a public health experiment in motion. J Clin Psychiatry. 2007;68(7):1139-1141. doi:10.408/JCP.v68n0723 (Pubitemid 47340337)
11. House Committee on Veterans' Affairs. Exploring the relationship between medication and veteran suicide. http://veterans.house.gov/hearings/hearing.aspx? NewsID=525. February 24, 2010. Accessed September 9, 2010.
12. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63(3):332-339. doi:10.101/archpsyc.63.3.32 (Pubitemid 43345358)
13. FDA News Release. FDA proposes new warnings about suicidal thinking, behavior in young adults who take antidepressant medications. www.fda.gov/bbs/topics/NEWS/2008/NEW1786.html. Published May 2, 2007. Accessed August 12, 2010.
14. Wang PS, Berglund P, Kessler RC. Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med. 2000;15(5):284-292. doi:10.1046/j.1525-1497. 20.90804.x (Pubitemid 30333825)
15. Wang PS, Berglund P, Olfson M, et al. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):603-613. doi:10.101/archpsyc.62.6.603 (Pubitemid 40973435)
16. Lineberry TW, Bostwick JM, Beebe TJ, et al. Impact of the FDA black box warning on physician antidepressant prescribing and practice patterns: opening Pandora's suicide box. Mayo Clin Proc. 2007;82(4):518-520. doi:10.4065/82.4.518
17. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67(5):507-516. doi:10.101/ archgenpsychiatry.2010.46
18. Cuijpers P, Smit F, Bohlmeijer E, et al. Efficacy of cognitive- behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias. Br J Psychiatry. 2010;196(3):173-178. doi:10.192/bjp.bp.109.0601
19. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-260. doi:10.1056/NEJMsa06579
20. Kocsis JH, Gelenberg AJ, Rothbaum BO, et al, for the REVAMP Investigators. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry. 2009;66(11):1178- 1188. doi:10.101/archgenpsychiatry.209.14
21. Schatzberg AF, Blier P, Delgado PL, et al. Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research. J Clin Psychiatry. 2006;67(suppl 4):27-30. (Pubitemid 43764535)